在骨科创伤和择期手术中使用细胞挽救术的最新趋势--综述。

Q4 Medicine
Georgian medical news Pub Date : 2024-09-01
A Sain, U Ghosh, J Chia, M Malik, N Manzoor, M Halasa, F Hussain, H Asim, K Wattage, H Manyar, A Elkilany, A Jindal, J Wilson, N Khayyat, H Burton, W Alfred, V Deshmukh, Z Sohail, N Shah
{"title":"在骨科创伤和择期手术中使用细胞挽救术的最新趋势--综述。","authors":"A Sain, U Ghosh, J Chia, M Malik, N Manzoor, M Halasa, F Hussain, H Asim, K Wattage, H Manyar, A Elkilany, A Jindal, J Wilson, N Khayyat, H Burton, W Alfred, V Deshmukh, Z Sohail, N Shah","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Intraoperative blood loss management is a critical concern in orthopaedic surgeries, particularly in trauma and complex elective procedures. Traditionally, allogeneic blood transfusions have been used to manage significant blood loss, but they carry risks such as transfusion reactions, infections, and increased healthcare costs. Cell salvage, or autotransfusion, offers a safer alternative by collecting, processing, and reinfusing the patient's own blood during surgery. This article explores recent trends in the use of cell salvage in orthopaedic trauma and elective surgeries, highlighting its growing adoption in high-blood-loss procedures such as pelvic fractures, long bone injuries, and revision arthroplasties. We discuss the indications, including use in patients with rare blood types, religious objections to donor blood, and pre-existing anaemia. The advantages of cell salvage, such as reducing dependency on allogeneic transfusions, minimizing transfusion reactions, and providing cost-effectiveness, are weighed against its limitations, including high initial costs, contraindications in certain procedures, and the need for specialized training. Recent advances in cell salvage technology, which enhance the safety and efficiency of the process, are also examined. As orthopaedic practices evolve toward more patient-centered, cost-effective care, the role of cell salvage is expected to grow, making it a valuable tool in modern blood management strategies.</p>","PeriodicalId":12610,"journal":{"name":"Georgian medical news","volume":" 354","pages":"42-44"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"RECENT TRENDS IN THE USE OF CELL SALVAGER FOR ORTHOPAEDIC TRAUMA AND ELECTIVE SURGERIES-A NARRATIVE REVIEW.\",\"authors\":\"A Sain, U Ghosh, J Chia, M Malik, N Manzoor, M Halasa, F Hussain, H Asim, K Wattage, H Manyar, A Elkilany, A Jindal, J Wilson, N Khayyat, H Burton, W Alfred, V Deshmukh, Z Sohail, N Shah\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Intraoperative blood loss management is a critical concern in orthopaedic surgeries, particularly in trauma and complex elective procedures. Traditionally, allogeneic blood transfusions have been used to manage significant blood loss, but they carry risks such as transfusion reactions, infections, and increased healthcare costs. Cell salvage, or autotransfusion, offers a safer alternative by collecting, processing, and reinfusing the patient's own blood during surgery. This article explores recent trends in the use of cell salvage in orthopaedic trauma and elective surgeries, highlighting its growing adoption in high-blood-loss procedures such as pelvic fractures, long bone injuries, and revision arthroplasties. We discuss the indications, including use in patients with rare blood types, religious objections to donor blood, and pre-existing anaemia. The advantages of cell salvage, such as reducing dependency on allogeneic transfusions, minimizing transfusion reactions, and providing cost-effectiveness, are weighed against its limitations, including high initial costs, contraindications in certain procedures, and the need for specialized training. Recent advances in cell salvage technology, which enhance the safety and efficiency of the process, are also examined. As orthopaedic practices evolve toward more patient-centered, cost-effective care, the role of cell salvage is expected to grow, making it a valuable tool in modern blood management strategies.</p>\",\"PeriodicalId\":12610,\"journal\":{\"name\":\"Georgian medical news\",\"volume\":\" 354\",\"pages\":\"42-44\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Georgian medical news\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Georgian medical news","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

术中失血管理是骨科手术中的一个关键问题,尤其是在创伤和复杂的择期手术中。传统上,异体输血用于控制大量失血,但存在输血反应、感染和医疗成本增加等风险。细胞挽救或自体输血通过在手术过程中收集、处理和再输患者自身的血液,提供了一种更安全的替代方法。本文探讨了在骨科创伤和择期手术中使用细胞复苏的最新趋势,重点介绍了在骨盆骨折、长骨损伤和翻修关节置换术等高失血手术中越来越多地采用细胞复苏。我们讨论了适应症,包括稀有血型患者、对献血有宗教抵触的患者以及原有贫血症患者。细胞复苏的优点包括减少对异体输血的依赖、最大限度地减少输血反应、成本效益高,但也有其局限性,包括初始成本高、某些手术的禁忌症以及需要专门培训。此外,还探讨了细胞挽救技术的最新进展,这些进展提高了细胞挽救过程的安全性和效率。随着骨科实践向着更加以病人为中心、更具成本效益的方向发展,细胞挽救的作用预计会越来越大,使其成为现代血液管理策略中的重要工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
RECENT TRENDS IN THE USE OF CELL SALVAGER FOR ORTHOPAEDIC TRAUMA AND ELECTIVE SURGERIES-A NARRATIVE REVIEW.

Intraoperative blood loss management is a critical concern in orthopaedic surgeries, particularly in trauma and complex elective procedures. Traditionally, allogeneic blood transfusions have been used to manage significant blood loss, but they carry risks such as transfusion reactions, infections, and increased healthcare costs. Cell salvage, or autotransfusion, offers a safer alternative by collecting, processing, and reinfusing the patient's own blood during surgery. This article explores recent trends in the use of cell salvage in orthopaedic trauma and elective surgeries, highlighting its growing adoption in high-blood-loss procedures such as pelvic fractures, long bone injuries, and revision arthroplasties. We discuss the indications, including use in patients with rare blood types, religious objections to donor blood, and pre-existing anaemia. The advantages of cell salvage, such as reducing dependency on allogeneic transfusions, minimizing transfusion reactions, and providing cost-effectiveness, are weighed against its limitations, including high initial costs, contraindications in certain procedures, and the need for specialized training. Recent advances in cell salvage technology, which enhance the safety and efficiency of the process, are also examined. As orthopaedic practices evolve toward more patient-centered, cost-effective care, the role of cell salvage is expected to grow, making it a valuable tool in modern blood management strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Georgian medical news
Georgian medical news Medicine-Medicine (all)
CiteScore
0.60
自引率
0.00%
发文量
207
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信